Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04092270
Title A Study Combining the M3814 Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer Patients
Recruitment Suspended
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCHealth University of Colorado Hospital Aurora Colorado 80045 United States Details
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
University of Wisconsin Carbone Cancer Center - University Hospital Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field